SC 13D/A

AMENDMENT NO. 4 TO THE SCHEDULE 13D

Company: LIFECORE BIOMEDICAL, INC. \DE\
Filed: August 24, 2020
Accession Number: 0000921895-20-002312

View Document ↗ View on SEC.gov ↗